Your Client Rank:
Loading...
99
Updated 07-Dec-2021
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Daiichi | 11.1% | 2.8% | -2.7% | -5.1% | 22.5% | 0.8% | 35.3% | 36.0% |
| Astra | 10.4% | 2.0% | -4.2% | -3.4% | 12.5% | 2.2% | 21.5% | 18.9% |
| Lilly | 10.3% | 0.9% | -5.0% | -6.1% | 7.2% | 2.6% | 17.7% | 18.2% |
| Eisai | 9.9% | 0.7% | 1.0% | -6.4% | 18.6% | 6.3% | 29.8% | 29.8% |
| Novo | 9.8% | 0.3% | -1.8% | 1.4% | 0.8% | 0.6% | 10.7% | 12.1% |
| Shionogi | 7.6% | -0.3% | -2.9% | -4.1% | 4.8% | 16.8% | 7.9% | 8.4% |
| Lundbeck | 7.3% | 0.9% | -3.2% | -5.1% | 16.8% | -0.7% | 19.9% | 19.9% |
| Vertex | 7.3% | 0.2% | 3.0% | -8.7% | 9.1% | 1.6% | 7.2% | 7.1% |
| Astellas | 6.5% | -0.1% | -3.6% | 0.3% | 7.7% | 3.0% | 13.5% | 17.2% |
| Merck | 5.5% | 1.1% | -3.0% | -1.7% | 3.7% | 1.6% | 9.8% | 10.9% |
| Sanofi | 5.3% | 1.0% | -3.8% | -2.2% | 5.7% | 0.0% | 9.2% | 9.3% |
| Biogen | 5.2% | 0.1% | -3.3% | -4.2% | 5.0% | 2.5% | 4.2% | 7.0% |
| Glaxo | 4.7% | 0.5% | -1.7% | -0.4% | 3.8% | 2.2% | 8.9% | 8.1% |
| Roche | 3.8% | 0.5% | -0.2% | -1.2% | 1.8% | 0.8% | 5.6% | 6.1% |
| Amgen | 2.9% | 0.0% | -0.6% | 0.4% | 0.0% | 2.1% | 4.0% | 6.1% |
| JnJ | 2.8% | 0.0% | -2.5% | -1.8% | 0.8% | 2.1% | 3.8% | 5.0% |
| Bayer | 2.4% | -0.1% | -0.5% | -0.9% | 2.7% | -23.1% | 6.4% | 6.9% |
| Novartis | 2.4% | 0.3% | -0.9% | -0.8% | 1.3% | 1.0% | 4.3% | 4.9% |
| Bristol | 2.0% | -1.0% | -1.5% | -0.8% | -0.1% | 0.4% | 2.1% | 2.7% |
| Chugai | 1.9% | 1.4% | 0.3% | 2.3% | 1.2% | -0.2% | 3.1% | 3.1% |
| AbbVie | 0.8% | -0.6% | 0.1% | 1.2% | -1.1% | 2.4% | 0.1% | 0.4% |
| Teva | 0.7% | 0.6% | -0.5% | -0.7% | 1.9% | 0.1% | 4.6% | 3.8% |
| Gilead | -0.1% | -0.3% | 1.8% | 2.7% | -2.3% | 0.0% | -2.2% | -1.3% |
| Takeda | -0.2% | 0.1% | -1.2% | 0.9% | 3.7% | -13.6% | 13.5% | 13.6% |
| Viatris | -0.3% | 1.0% | -3.0% | 1.9% | 1.0% | 0.7% | 2.1% | 2.0% |
| Regeneron | -4.8% | 0.4% | 5.9% | 6.9% | -5.0% | 2.1% | -9.4% | -9.7% |
| Pfizer | -7.1% | 5.7% | 8.0% | 7.0% | 5.4% | -0.9% | -1.7% | -1.3% |
| EU Major | 5.0% | 0.8% | -1.8% | -1.3% | 4.0% | 0.7% | 8.7% | 8.4% |
| Other EU | 7.3% | 0.9% | -3.2% | -5.1% | 16.8% | -0.7% | 19.9% | 19.9% |
| US Major | 1.4% | 1.2% | -0.3% | 0.2% | 2.0% | 1.1% | 3.7% | 6.4% |
| US Big Biotech | 1.4% | -0.1% | 0.9% | 0.2% | -0.3% | 1.4% | -0.2% | -1.9% |
| Other US | 0.2% | 0.8% | -1.7% | 0.5% | 1.3% | 0.4% | 3.1% | 2.7% |
| Japanese | 4.3% | 0.8% | -0.8% | -0.8% | 6.5% | -2.9% | 13.4% | 15.7% |
